3-Ethyl-2-methylbenzo[d]thiazol-3-ium iodide

Catalog No. :
ACQLUJ381
CAS No. :
3119-93-5
Molecular Formula :
C10H12INS
Molecular Weight :
305.18

IUPAC Name:3-ethyl-2-methylbenzo[d]thiazol-3-ium iodide

3-Ethyl-2-methylbenzo[d]thiazol-3-ium iodide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$160.00Login to see priceIn stockIn stock
100g98%$624.00Login to see priceIn stockIn stock
500g98%$2496.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Ethyl-2-methylbenzo[d]thiazol-3-ium iodide
IUPAC Name3-ethyl-2-methylbenzo[d]thiazol-3-ium iodide
MDL No.MFCD00044134
Molecular FormulaC10H12INS
Molecular Weight305.18
SMILESCC1=[N+](CC)C2=CC=CC=C2S1.[I-]
InChI KeyHWFCSPDBFXYFKY-UHFFFAOYSA-M
SynonymYSZC1863 | MFCD00044134 | AKOS001026937 | J-018277 | E0476 | 3-ethyl-2-methylbenzo[d]thiazol-3-iumiodide | SCHEMBL56400 | A876008 | 3-Ethyl-2-methylbenzothiazolium iodide | Benzothiazolium, 3-ethyl-2-methyl-, iodide | 3-ethyl-2-methyl-1,3-benzothiazol-3-i
CAS No.3119-93-5
PubChem CID2729630

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACQLUJ381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLVNB781 route compound structure diagram
    ACLVNB781120-75-2 In Stock
  4. Then
  5. ACQLUJ381 route product structure diagram
    ACQLUJ3813119-93-5 In Stock
Inquiry

2. ACQLUJ381 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLVNB781 route compound structure diagram
    ACLVNB781120-75-2 In Stock
  4. Then
  5. ACQLUJ381 route product structure diagram
    ACQLUJ3813119-93-5 In Stock
Inquiry

Comments (0)